Transform Materials achieves milestone in commercial-scale production plans

In Florida, Transform Materials LLC, a chemical company with a patented net-carbon-negative process to cost-effectively produce commercial acetylene and hydrogen, reached a key milestone in scaling its global production capability. Transform and DSM Nutritional Products began discussions for global-scale commercial production.

Transform in alignment with its licensing partner, DSM Nutritional Products Ltd, part of Netherlands-based Royal DSM with global products and services in nutrition, health and sustainable living, declare the successful operation of Transform’s pilot chemical plant in Riviera Beach, Fla., which paves the way for the development of large-scale commercial production. Transform conducted more than 6 months of testing and evaluation to complete and meet the rigorous milestone targets proving a 99% operational uptime.

Under the licensing agreement, Transform has granted DSM certain rights to Transform’s patented technology when used in the production of vitamins, carotenoids and nutritional ingredients. DSM’s Improve, Enable, Advocate strategy aims to enable low-carbon energy solutions that support the transition to a low carbon economy and at the same time offers further greenhouse gas (GHG) reduction opportunities for customers.